Switzerland· 46673054
Salofalk 1g, Zäpfchen
A mesalazine product containing mesalazinum, registered in Switzerland by Dr. Falk Pharma AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Mesalazine is registered in 17 of 19 countries.
Countries holding a registration under ATC A07EC02 (mesalazine), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Mesalazine · ATC A07EC02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mesalazine costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.00 in Italy to $2.13 in Switzerland — a ×2.1 gap.
- Switzerland: $2.13 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mesalazine · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.13
- FR France$1.06
- IT Italy$1.00
The record
At a glance
Swissmedic (Switzerland)- Active substance
- mesalazinum
- Manufacturer
- Dr. Falk Pharma AG
- Country
- Switzerland (CH)
- ATC code
- A07EC02
- ATC class
- Mesalazine
- Defined daily dose
- 1.5 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680466730548Blist 60 StkCHF 140.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
333 interactions on record for mesalazine.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mesalazine · interactions on record
333 records
- 15 severe
- 95 moderate
- 223 info
Most severe, free to view
- CidofovirJ05AB12severe
- Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
- Humane Immunglobuline, unspezifisch, intravaskulärJ06BA02severe
- SirolimusL01EG04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mesalazine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaASACOLTillotts Pharma GmbH, Rheinfelden
- SwedenAsacol 1 g SuppositoriumTillotts Pharma AB
- United StatesCanasaAllergan, Inc.
- IrelandAsacolon 1000 mg SuppositoryTillotts Pharma GmbH
- FinlandAsacolTillotts Pharma AB
- NorwayAsacolTillotts Pharma AB (2)
- PolandCrohnaxFarmina Sp. z o.o.
- NetherlandsKiudro 1 g zetpilTillotts Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Azzavix, Claversal
- Belgium · Asamovon, Claversal
- Bulgaria · Salofalk – Салофалк, Пентаза
- Cyprus · Asacol, Mecolzine
- Czechia · Asacol, Asacol Enema
- Germany · Asacol, Claversal
- Denmark · Asacol, Mesalazin Orion
- Estonia · Asacol, Pentasa
- Spain · Asacol, Azzavix
- Finland · Asacol, Asacol 1 G
- France · Fivasa, Mazalvix
- United Kingdom (Northern Ireland) · Asacol, Mesalazine
- Greece · Asacol, Asalazin
- Croatia · Pentasa, Salofalk
- Hungary · Pentasa, Salofalk
- Ireland · Asacolon, Galtasa
- Iceland · Asacol, Pentasa
- Italy · Argonal, Asacol
- Lithuania · Asacol, Pentasa
- Luxembourg · Claversal, Claversal Foam
- Latvia · Asacol, Pentasa
- Malta · Mecolzine, Mezavant Xl
- Netherlands · Asacol, Azzavix
- Norway · Asacol, Mesalazin Orion
- Poland · Crohnax, Granmesa
- Portugal · Asacol, Azzavix
- Romania · Mesalazina Alfasigma, Pentasa
- Sweden · Asacol, Mesalazin Orion
- Slovenia · Asacol, Asacol®
- Slovakia · Pentasa, Pentasa Sachet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f187d6b4-b632-424e-97e7-5b47595362f7 GET /v1/drugs/f187d6b4-b632-424e-97e7-5b47595362f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "mesalazinum 1000 mg",
"valid_from": "2011-05-01",
"limitations": "[{\"description\":\"Proctitis und Proctosigmoiditis\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2012-01-01\"}]",
"galenic_form": "Supp 1 g",
"therapeutic_area": null,
"sl_inclusion_date": "2011-05-01",
"self_retention_pct": 10
}See everything about mesalazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.